Cellectar’s commitment to research and development of an innovative pipeline through collaboration and manufacturing of quality drug products motivates us daily. The potential to diagnose and treat cancer patients by providing the highest quality specialized treatments creates a rewarding environment for its employees.
Cellectar‘s goal is to improve the lives of cancer patients through innovation, collaboration, and the manufacturing of our targeted drug delivery technologies.
The Board of Directors of Cellectar Biosciences (the “ Company”) sets high standards for the Company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company’s business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.